search
Back to results

In Vivo Three-Dimensional Determination of Osteoarthritis Brace Effectiveness

Primary Purpose

Osteoarthritis, Knee

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Breg Osteoarthritis Brace gait fluoroscopy
Gait fluoroscopy without brace
JointVue ultrasound
Computer Tomography
Sponsored by
The University of Tennessee, Knoxville
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis, Knee

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Must be a patient of Colorado Joint Replacement.
  • Must be diagnosed with marked unicompartimental degenerative joint space narrowing.
  • Bilateral subjects may not be included in the subject population

Exclusion Criteria:

  • Pregnant, potentially pregnant or lactating females. To satisfy radiation protocol, each female subject will be asked if she is pregnant, or possibly could be pregnant. A pregnant person will not be allowed to participate in the study.
  • Subjects who are unable to perform normal walking.
  • Subjects who are unwilling to sign Informed Consent/ HIPAA documents.
  • Does not speak English.

Sites / Locations

  • Colorado Joint Replacement
  • Porter Adventist Hospital
  • University of Tennessee

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Subjects diagnosed with osteoarthritis of the knee

Arm Description

Subjects must be diagnosed with marked unicompartimental degenerative joint space narrowing.

Outcomes

Primary Outcome Measures

Medial Condylar Separation With Brace
Medial condylar separation during gait
Medial Condylar Separation Without Brace
Medial condylar separation during gait

Secondary Outcome Measures

Full Information

First Posted
September 23, 2019
Last Updated
October 7, 2021
Sponsor
The University of Tennessee, Knoxville
Collaborators
BREG, Inc
search

1. Study Identification

Unique Protocol Identification Number
NCT04111276
Brief Title
In Vivo Three-Dimensional Determination of Osteoarthritis Brace Effectiveness
Official Title
In Vivo Three-Dimensional Determination of Osteoarthritis Brace Effectiveness
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
July 12, 2019 (Actual)
Primary Completion Date
November 6, 2020 (Actual)
Study Completion Date
November 6, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Tennessee, Knoxville
Collaborators
BREG, Inc

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
In vivo knee kinematics will be assessed for 20 subjects that have been clinically diagnosed with substantial unicompartmental osteoarthritis (OA) by one of the surgeons of Colorado Joint Replacement; this is the location from which participants will be recruited. The objective of this study will be to analyze subjects with symptomatic unicompartmental osteoarthritis under in vivo dynamic, weight-bearing conditions using video fluoroscopy to determine if present-day OA knee braces provide separation of the femoral condyle from the tibial plateau, thus avoiding excessive loads on the degenerative compartment.
Detailed Description
In vivo knee kinematics will be assessed for 20 subjects that have been clinically diagnosed with substantial unicompartmental osteoarthritis (OA) by one of the surgeons of Colorado Joint Replacement; this is the location from which participants will be recruited. Enrollment will be increased to 24 subjects to account for any dropouts. Medial joint space narrowing will be clinically assessed in all patients on standing anteroposterior radiographs. The objective of this study will be to analyze subjects with symptomatic unicompartmental osteoarthritis under in vivo dynamic, weight-bearing conditions using video fluoroscopy to determine if present-day OA knee braces provide separation of the femoral condyle from the tibial plateau, thus avoiding excessive loads on the degenerative compartment. Subjects will be asked to perform gait without the assistance of an offloading brace while under fluoroscopic evaluation. Then, each subject will be fitted with a Breg, off-the-shelf OA brace and will perform normal gait while under fluoroscopic surveillance. To ensure each brace was fitted properly, Breg will be asked to send either a sales representative or an engineer to the evaluation site. Therefore, the sales representative or engineer will be asked to fit their brace on each of the subjects. Since the skeletal geometry is different for every person, computer aided design (CAD) models of the femur and tibia will be created for each specific subject. In order to create these CAD models, each subject will be asked to undergo a three-dimensional (3D) ultrasound using the JointVue proprietary software to reconstruct 3D femoral and tibial bones. A representative from JointVue will be present during data collection to conduct the ultrasound procedure in order to create the CAD models. Participants will be asked to schedule a CT scan at Porter Adventist Hospital at their convenience to aid in the development of the bone models. To ensure subject safety, CT will be limited to the affected knee and the rest of patient's body will be protected from radiation with lead protection. The CT scan will be limited to the study knee and will image 6 inches distal on the tibia and 6 inches proximal on the femur.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Knee

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
23 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Subjects diagnosed with osteoarthritis of the knee
Arm Type
Experimental
Arm Description
Subjects must be diagnosed with marked unicompartimental degenerative joint space narrowing.
Intervention Type
Device
Intervention Name(s)
Breg Osteoarthritis Brace gait fluoroscopy
Intervention Description
Gait under fluoroscopy surveillance with brace
Intervention Type
Other
Intervention Name(s)
Gait fluoroscopy without brace
Intervention Description
Gait under fluoroscopy surveillance without brace
Intervention Type
Diagnostic Test
Intervention Name(s)
JointVue ultrasound
Intervention Description
JointVue ultrasound procedure to reconstruct 3D femoral and tibial bones
Intervention Type
Diagnostic Test
Intervention Name(s)
Computer Tomography
Intervention Description
Computer Tomography scan limited to the study knee and will image 6 inches distal on the tibia and 6 inches proximal on the femur
Primary Outcome Measure Information:
Title
Medial Condylar Separation With Brace
Description
Medial condylar separation during gait
Time Frame
One day
Title
Medial Condylar Separation Without Brace
Description
Medial condylar separation during gait
Time Frame
One day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Must be a patient of Colorado Joint Replacement. Must be diagnosed with marked unicompartimental degenerative joint space narrowing. Bilateral subjects may not be included in the subject population Exclusion Criteria: Pregnant, potentially pregnant or lactating females. To satisfy radiation protocol, each female subject will be asked if she is pregnant, or possibly could be pregnant. A pregnant person will not be allowed to participate in the study. Subjects who are unable to perform normal walking. Subjects who are unwilling to sign Informed Consent/ HIPAA documents. Does not speak English.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard Komistek, PhD
Organizational Affiliation
University of Tennessee
Official's Role
Principal Investigator
Facility Information:
Facility Name
Colorado Joint Replacement
City
Denver
State/Province
Colorado
ZIP/Postal Code
80210
Country
United States
Facility Name
Porter Adventist Hospital
City
Denver
State/Province
Colorado
ZIP/Postal Code
80210
Country
United States
Facility Name
University of Tennessee
City
Knoxville
State/Province
Tennessee
ZIP/Postal Code
37996
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Researchers would like to retain this study data in our secure database so as to continue to add relevant, current data to our digital collection to help us work with manufacturers in the future to create better implants that last longer and will not require revision surgery. Participants will be asked if their study data may remain a part of the University of Tennessee's Center for Musculoskeletal Research data collection for use in future studies in the IC. Identifiers are automatically removed from the database upon entry into the secure server. Data shared with sponsors is de-identified.

Learn more about this trial

In Vivo Three-Dimensional Determination of Osteoarthritis Brace Effectiveness

We'll reach out to this number within 24 hrs